By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Innovation Pharmaceuticals Inc.

Innovation Pharmaceuticals Inc. (IPIX)

OTC Currency in USD
$0.00
$0.00
-50.00%
Last Update: 3 Sept 2025, 17:09
$1.07M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.02
52 Week Range

IPIX Stock Price Chart

Explore Innovation Pharmaceuticals Inc. interactive price chart. Choose custom timeframes to analyze IPIX price movements and trends.

IPIX Company Profile

Discover essential business fundamentals and corporate details for Innovation Pharmaceuticals Inc. (IPIX) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

4 May 2007

Employees

4.00

CEO

Leo Ehrlich CPA

Description

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company is also developing Kevetrin, an anti-cancer compound for treating ovarian cancer. It has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.

IPIX Financial Timeline

Browse a chronological timeline of Innovation Pharmaceuticals Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 19 Nov 2024

Earnings released on 27 Sept 2024

Earnings released on 29 May 2024

Earnings released on 12 Feb 2024

Earnings released on 20 Nov 2023

EPS came in at -$0.00 .

Earnings released on 28 Sept 2023

EPS came in at -$0.00 , while revenue for the quarter reached -$6.00K .

Earnings released on 15 May 2023

EPS came in at -$0.00 .

Earnings released on 15 Feb 2023

EPS came in at -$0.00 .

Earnings released on 10 Nov 2022

EPS came in at -$0.00 .

Earnings released on 28 Sept 2022

EPS came in at -$0.00 , while revenue for the quarter reached $18.00K .

Earnings released on 13 May 2022

EPS came in at -$0.00 .

Earnings released on 14 Feb 2022

EPS came in at -$0.00 .

Earnings released on 9 Nov 2021

EPS came in at -$0.00 .

Earnings released on 27 Sept 2021

EPS came in at -$0.01 .

Earnings released on 13 May 2021

EPS came in at -$0.01 .

Earnings released on 22 Feb 2021

EPS came in at -$0.02 .

Earnings released on 16 Nov 2020

EPS came in at -$0.00 , while revenue for the quarter reached -$609.00K .

Earnings released on 14 Sept 2020

EPS came in at -$0.01 , while revenue for the quarter reached $23.00K .

IPIX Stock Performance

Access detailed IPIX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run